Effects of Naproxen on Physical Performance

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-05-31

Study Completion Date

2006-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effect of daily use of Naproxen (a commonly used over-the-counter NSAID) on the physical performance of athletes, as measured by maximum oxygen consumption.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Physically fit volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Naproxen

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age equal to or greater than18 years of age
2. No history of allergy or adverse reaction to any NSAID
3. No use of any NSAID in past 2 weeks
4. No history of peptic ulcer disease (PUD), gastroesophageal disease (GERD), or gastritis
5. No major medical history including but not limited to diabetes, hypertension, asthma, kidney disease and coronary artery disease
6. Currently not taking any medication including oral contraceptives

Exclusion Criteria

1. Age \< 18 years of age
2. History of allergy or adverse reaction to any NSAID
3. Use of any NSAID in past 2 weeks
4. History of a bleeding disorder
5. History of PUD, GERD, or gastritis
6. Pregnant
7. A medical history of diabetes, hypertension, asthma, kidney disease or coronary artery disease
8. Taking any medication including oral contraceptives

Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

LaMont Cavanagh, MD

Role: PRINCIPAL_INVESTIGATOR

University of Oklahoma-Tulsa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Family Practice - CMT

Tulsa, Oklahoma, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11186

Identifier Type: -

Identifier Source: org_study_id